Early-onset dementia may be detectable up to 15 years before a clinical diagnosis through patterns of declining work performance and income loss, according to a study from the University of Eastern Finland. Researchers found that individuals who later developed the condition earned significantly less and left the workforce earlier than healthy peers.
Work Performance as a Warning Sign for Early-Onset Dementia
Declining cognitive health often manifests in the workplace long before a patient meets the criteria for a medical diagnosis. Dr. Eino Solje, a neurologist at the University of Eastern Finland in Kuopio, led a study published July 8 that tracked 793 patients with early-onset dementia and 7,000 healthy individuals over a 12-year period.
The data revealed a measurable financial impact. Patients with early-onset dementia earned an average of $13,000 less per year than the healthy control group. This resulted in an annual wage loss of roughly $86,000 over the course of the study. Researchers attributed this gap to patients taking extended work breaks or retiring early due to cognitive decline.
Did you know? Early-onset dementia specifically affects individuals under the age of 65, often masking symptoms as professional burnout or mid-life stress.
Diagnosis Timelines: Alzheimer’s vs. Frontotemporal Dementia
The Finnish study identified different “warning windows” depending on the specific type of dementia. The timeline for when earnings began to drop varies by condition:
- Frontotemporal Dementia (FTD): Earnings began to decrease 11 years before a formal diagnosis.
- Early-Onset Alzheimer’s: Earnings showed a reduction 6 years before the official diagnosis.
These findings align with high-profile cases like actor Bruce Willis. Willis retired in March 2022 following a diagnosis of aphasia, which later progressed to frontotemporal dementia. His wife, Emma Heming Willis, told Town & Country in 2024 that FTD “whispers” rather than shouts, making the initial decline difficult to pinpoint.
Genetic Risks and Proactive Health Management
While some cases appear sudden, genetic markers can provide a roadmap for risk. Actor Chris Hemsworth discovered through a genetic test for his Disney+ series, Limitless, that he carries copies of the APOE4 (apolipoprotein E) gene from both parents. This inheritance puts his risk of developing Alzheimer’s eight to 10 times higher than most.
Hemsworth told Vanity Fair that this information prompted him to take a six-month break from work between the winter of 2022 and the summer of 2023 to focus on his family and prioritize “stillness and gratitude.”
Pro Tip: If a high-functioning person experiences persistent difficulties with tasks they have performed for years, Dr. Edmundo Rodriguez-Frias of the New Jersey-based recovery center Full of Life advises consulting a doctor rather than dismissing the changes as work-related stress.
Identifying Red Flags and Risk Factors
The National Institutes of Health reports that over 6 million Americans live with dementia. It remains a leading cause of death, affecting roughly one in three seniors—a mortality rate higher than breast and prostate cancer combined.
According to the University of Eastern Finland researchers, early red flags include:
- Difficulty concentrating or following conversations.
- Forgetting appointments.
- Struggling with long-term routine tasks.
- Severe mood swings or unusual distrust of family in later stages.
The study also noted that certain lifestyle and medical histories increase risk, specifically previous strokes, brain injuries, or heavy liquor use.
Frequently Asked Questions
What is the difference between Alzheimer’s and FTD in terms of early signs?
According to the University of Eastern Finland study, FTD may show signs of work performance decline 11 years before diagnosis, while Alzheimer’s typically shows signs 6 years prior.
Can early-onset dementia be cured?
There is currently no cure, but the study notes that available treatments can help slow the progression of the disease, making early detection essential.
What is the APOE4 gene?
As seen in the case of Chris Hemsworth, APOE4 is a genetic marker that can significantly increase a person’s susceptibility to Alzheimer’s disease.
Want to stay informed on the latest neurological research?
Subscribe to our newsletter for deep dives into health trends and medical breakthroughs.
Keep reading